People: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

19 Dec 2014
Price Change (% chg)

$0.06 (+0.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Dingemans, Simon 

Brief Biography

Mr. Simon Dingemans is Chief Financial Officer, Executive Director of GlaxoSmithKline plc. Prior to joining GSK, Simon had over 25 years of experience in investment banking at SG Warburg and Goldman Sachs. During this time, he advised a broad range of large corporates across a number of industry sectors, including pharmaceuticals and consumer healthcare. Simon advised GSK for over a decade before his appointment and was closely involved in a number of GSK’s key strategic projects, including the establishment of ViiV Healthcare. Simon is a member of the Corporate Development Council for the National Theatre and Deputy Chairman of the 100 Group.

Basic Compensation

Total Annual Compensation, GBP Long-Term Incentive Plans, GBP All Other, GBP Fiscal Year Total, GBP
1,650,000 1,502,000 140,000 3,292,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Christopher Gent


Andrew Witty


Simon Dingemans


Moncef Slaoui


Deirdre Connelly


Roger Connor

As Of 30 Dec 2013
Search Stocks